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Abstract
Background: Previous studies have identified lung, sputum or blood transcriptomic biomarkers associated with the
severity of airflow limitation in COPD. Yet, it is not clear whether the lung pathobiology is mirrored by these surrogate
tissues. The aim of this study was to explore this question.
Methods: We used Weighted Gene Co-expression Network Analysis (WGCNA) to identify shared pathological mechanisms
across four COPD gene-expression datasets: two sets of lung tissues (L1 n= 70; L2 n= 124), and one each of induced
sputum (S; n= 121) and peripheral blood (B; n = 121).
Results: WGCNA analysis identified twenty-one gene co-expression modules in L1. A robust module preservation between
the two L datasets was observed (86%), with less preservation in S (33%) and even less in B (23%). Three modules
preserved across lung tissues and sputum (not blood) were associated with the severity of airflow limitation. Ontology
enrichment analysis showed that these modules included genes related to mitochondrial function, ion-homeostasis, T
cells and RNA processing. These findings were largely reproduced using the consensus WGCNA network approach.
Conclusions: These observations indicate that major differences in lung tissue transcriptomics in patients with COPD
are poorly mirrored in sputum and are unrelated to those determined in blood, suggesting that the systemic
component in COPD is independently regulated. Finally, the fact that one of the preserved modules associated with
FEV1 was enriched in mitochondria-related genes supports a role for mitochondrial dysfunction in the pathobiology
of COPD.
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Background
Chronic Obstructive Pulmonary Disease (COPD) is de-
fined, and its severity graded, simply by the presence of
persistent airflow limitation, as determined by the forced
expiratory volume in 1 s (FEV1) and the ratio of FEV1 to
forced vital capacity (FVC) [1]. However, COPD is a
complex and heterogeneous disease, both clinically [2]
and molecularly [3, 4], and often patients have both pul-
monary and systemic manifestations [5]. On the other
hand, since the lung parenchyma is difficult to access,
the pathobiology of COPD is often studied in surrogate
tissue samples, such as sputum or circulating blood. In
these surrogate tissues, different mRNAs whose expres-
sion is associated with the severity of airflow limitation
have been identified. [6–11] Yet, the relationship of
changes in these surrogate tissues with those occurring
in the lung parenchyma is unclear.
Network analysis is a novel research strategy well-suited
to integrate and analyze complex data sets and to investi-
gate complex and heterogenous diseases such as COPD
[3, 12]. Weighted gene co-expression network correlation-
based analysis (WGCNA) is a particular type of network
analysis that allows the identification of modules of
co-expressed genes in a given transcriptomic dataset, the
investigation of the degree of module preservation in
other datasets, and the study of their relationship with
clinical features of interest [13–15]. This network based
comparison can be performed using data from different
technological platforms [13–15]. Here, we used WGCNA
to meta-analyse four previously published COPD tran-
scriptomic datasets determined in lung tissue (L), blood
(B) and sputum (S) [3, 16–18] (1) to identify L modules re-
lated with FEV 1, (2) to investigate if these L modules are
preserved in S and/or B data sets, and (3) to investigate
the biological processes associated with these modules.
Methods
Methods are detailed in the Additional file 1.
Participants and data sets
We used four transcriptomic datasets generated by three
different COPD studies in Lung (L1 [3] and L2 [16]), in-
duced sputum (S) and circulating blood (B) [17, 18]. L1
included 70 lung tissue samples obtained from COPD
patients who spanned all GOLD grades (1–4) of airflow
limitation severity [3], L2 included 90 lung tissue sam-
ples from COPD patients with GOLD grades 3–4 and 34
former smokers with normal lung function. The S and B
datasets were obtained from 121 COPD patients in-
cluded in the ECLIPSE study with GOLD grades 2–4
[17]. To avoid a potential confounder effect of active
smoking on transcriptomics, all participants were former
smokers, who had been abstinent from smoking for at
least one month before tissue sampling. The selected
datasets fulfilled the following criteria: including former
smokers with COPD (to avoid the influence of the active
smoking exposure in the transcriptomic results), large
sample size (n > =70), being of the same individual
(blood and sputum).
Ethics statement
The Ethic Committees of the participating institutions
approved each of these three studies, and all participants
provided written informed consent prior to the perform-
ance of any study procedures.
Gene expression
The methodology for microarray hybridization has been
described previously [3, 16–18]. All datasets are available
on the Gene Expression Omnibus website, http://
www.ncbi.nlm.nih.gov/geo/ (GSE69818, GSE4837, GSE22
148 and GSE76925). The array platforms used in each
cohort were: i) L1, Human Genome U219 Array Plate
(Affymetrix, Santa Clara, CA, USA), ii) L2, HumanHT-12
v4 Expression BeadChip Kit (Illumina, San Diego, USA);
and iii) S and B (ECLIPSE), HG_Plus_2.0 GeneChips
(Affymetrix, Santa Clara, CA, USA).
qPCR validation
In 20 additional lung tissue samples, recruited at Hos-
pital Clinic of Barcelona (characteristics provided in the
Additional file 1), the expression of MPV17L2, TSFM,
and NDUFA3 was assessed by qPCR using TaqMan as-
says and 2ΔCP with ACTB as the housekeeping gene,
based on previously described methods [3].
Data analysis
Quantitative clinical data is presented as mean ± stand-
ard deviation and compared between groups using
one-way ANOVA. Microarray pre-processing of each
dataset has been previously described [3, 16–18]. For the
present analysis, probes in the lowest quartile of variabil-
ity were removed, and array probes were collapsed to
genes, yielding 10,434 genes for final analysis.
Weighted gene co-expression network meta-analysis
The WGCNA meta-analysis was performed using the
WGCNA R package [13, 14] following the previously de-
scribed meta-analysis pipeline [15]. A step by step tutor-
ial on how to perform the WGCNA package can be
found at: https://horvath.genetics.ucla.edu/html/Coex-
pressionNetwork/Rpackages/WGCNA/Tutorials/.
Briefly, we first calculated the correlation matrix and
defined the WGCNA co-expression modules (labelled by
colour) in L1. The adjacency matrix for each data set
was built using the biweight midcorrelation, with a
softpower threshold of 12. The DeepSplit for module
identification in LT-1 was 1 and the minimum module
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size 30. WGCNA produces a set of modules (labeled by
color), each containing a set of unique genes. Next, the
preservation of the modules across the other three data-
sets was assessed using the modulePreservation function
with 100 permutations; Zsummary values > 5 were con-
sidered as preserved modules [15, 19]. The module
eigengene value (i.e., the first principal component of the
expression matrix of the probes within the module) was
calculated and used to test for association with the se-
verity of airflow limitation (as expressed by the FEV1%
predicted) after adjusting for gender and body mass
index (BMI) [20]. False discovery rate (FDR) < 0.05 was
used to define association. Driver genes were identified as
those with highest Module Membership (kME) in LT1
modules that also have highest kME in the same modules
in the other datasets [15]. To test the association of blood
gene expression with level of airflow limitation and verify
the lack of association, WGCNA modules were defined
for this dataset independently of the others, and their as-
sociation with FEV1 was calculated.
Enrichment analysis
To identify over-represented pathways in co-expression
modules related to FEV1% predicted, we used hypergeo-
metric tests in the R Bioconductor package GeneAnswers
[21], the Vignettes describing how to use the pipeline are
available from Bioconductor (https://www.bioconductor.-
org/). Significant enrichment was defined as FDR < 0.05,
with five or more genes associated to the term. To evaluate
the term overlap and obtain a visual summary we used
REVIGO [22], a tutorial is available at: http://revigo.irb.hr/).
Consensus network
A WGCNA consensus network was built using data
from L1, L2 and S using the blockwiseConsensusMo-
dules function with a softpower of 12, minModuleSize of
30, a maxBlockSize of 10,434, a corType “bicor”, and the
network and the TOM were signed [19]. Then, we used
linear regression with adjustment for gender and BMI to
identify modules associated with FEV1% predicted [20].
Results
Characteristics of participants
Table 1 describes the main characteristics of partici-
pants. All patients were Caucasians and former smokers.
There were more women in the L2 cohort, and ECLIPSE
participants had smoked fewer pack-years, but age and
BMI were similar across the three studies.
Network based transcriptomic meta-analysis
Using WGCNA [13], we identified 21 modules with a
minimum size of 30 genes in the L1 (Fig. 1, panel A).
These modules were also identified in L2, S and B datasets
(Fig. 1, panels B/C/D). Using the Z preservation score, we
ranked their preservation across datasets (Table 2).
Z-score values > 5 are considered preserved modules [19].
Four modules (19%) were preserved across all datasets
(Table 2). Eighteen modules (86%) were preserved in the
two lung tissue datasets, whereas seven (33%) were also
preserved in sputum, and five (24%) were preserved in
blood (Table 2). The negative control, a random selection
of genes (gold module), was not preserved in any group.
Association with lung function
To investigate the relationships between identified mod-
ules and FEV1, we performed a linear regression of each
module Eigengene with the FEV1% predicted as the
dependent variable, after adjusting for covariates (gender
and BMI). Results are displayed in the form of a heat
map in Fig. 2 (p-value and effect estimate). No blood
module was associated with FEV1% at p < 0.05, even
when the module definition was done in the blood
dataset, (Additional file 2: Figure S1). By contrast, 8
modules (38%) were significantly associated with airflow
Table 1 Characteristics of the 3 cohorts (4 transcriptomic datasets)
L1 L2 ECLIPSE
Sample Type and GEO accession number Lung Tissue Lung Tissue Sputum & Blood p value
GSE69818 GSE76925 GSE22148, GSE76705
Number of COPD/Controls 70/0 90 /34 121/0
Gender (M/F) 63/7 57/67 81/40 0.0005
Age 66.3 ± 8.6 64.3 ± 7.3 65.1 ± 5.5 ns
Current/Former Smokers 0/70 0/124 0/121 ns
Pack-years of smoking 56.5 ± 26.1 57.2 ± 28.6 47.1 ± 29.2 0.012
BMI 27.5 ± 4.5 26.2 ± 4.6 26.6 ± 4.9 ns
FEV1% predicted 57.9 ± 21.1 46.1 ± 34.0 48.9 ± 15.1 < 0.0001
FEV1/FVC 52.8 ± 12.3 45.1 ± 22.8 42.6 ± 11.8 0.0075
ns: non-significant p value > 0.05. GEO = gene expression omnibus
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limitation in L1, 6 (28%) in L2, and 17 (81%) in S; 3 of
them were preserved in L1, L2 and S: yellow (329 genes),
brown (345 genes) and magenta (142 genes) modules
(Fig. 2, Table 2 and Additional file 3: Table S1). The yel-
low module (Fig. 3a, Additional file 4: Table S2) included
ontologies related to mitochondrial function, signal
transduction by p53, hydrogen ion transmembrane
transport and MHC class I antigen processing/presenta-
tion. Accordingly, KEGG pathways analysis showed en-
richment in oxidative phosphorylation, metabolic and
spliceosome pathways (Additional file 5: Table S3). The
brown module (Fig. 3b, Additional file 4: Table S2) in-
cludes ontologies related to endocytosis, lysosome
organization, ion homeostasis, nucleotide metabolism
and T cell activation. KEGG pathway analysis showed
enrichment in Lysosome and Phagosome pathways
(Additional file 5: Table S3). Finally, the magenta module
(Fig. 3c, Additional file 4: Table S2) includes ontologies
related to noncoding RNA metabolism, cellular response
to cytokine stimulus and iron transmembrane transport.
KEGG analysis showed enrichment in the Ribosome bio-
genesis pathway (Additional file 5: Table S3).
We defined driver genes in a module as those genes
both associated with the severity of airflow limitation
and also highly correlated with other genes in that mod-
ule in all datasets (see methods) [15]. Table 3 lists the
driver genes in the three modules of interest and
highlighted in bold those genes that are included the
enriched gene ontology categories. In the yellow module,
ANAPC11, ATP5G1, ATP5G2, and NDUFA13 were in-
cluded in the mitochondrial related ontologies. In the
brown module, APEH and GPI were included in the me-
tabolism related ontologies. In the magenta module
ABCE1, MKI67IP, RIOK1, TIMM17A and WDR43 were
included in the RNA related ontologies.
Only one module, Lightcyan, was preserved and asso-
ciated with FEV1% in both lung tissue datasets but not
in blood or sputum (Fig. 2, Table 2). Interestingly this
module contained a set of genes related to B-lymphocyte
biology (Additional file 4: Table S2).
A B
C D
Fig. 1 Co-expression network dendrograms in the 4 datasets. (a) L1 co-expression network, with twenty-one modules with a minimum module
size of 30. (b) L2 co-expression network. (c) Blood co-expression network. (d) Sputum co-expression network. The color code in parts B, C, and D
corresponds to the modules identified in L1 (part A). For further details on analytical method
see: (https://horvath.genetics.ucla.edu/html/CoexpressionNetwork/Rpackages/WGCNA/Tutorials/)
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Consensus co-expression network of lung tissue and
sputum
The network meta-analysis method does not assume
module preservation, yet we identified multiple modules
that are highly preserved in the other lung tissue dataset
and the sputum datasets. To verify these results, we built
a consensus network including the two lung tissue data
sets and the sputum data set (as detailed in Additional
file 1), which assumes preservation between datasets.
Blood was not included, since none of the blood mod-
ules were related to the level of airflow limitation.
The consensus WGCNA network identified 14 con-
sensus modules (Additional file 6: Figure S2). Figure 4
shows the overlapping gene composition between these
14 consensus modules and the 21 WGCNA modules de-
rived from lung tissue. The yellow WGCNA module and
the brown consensus module shared 56.2% of their
genes. The brown WGCNA module and the green con-
sensus module shared 31.6% of genes. The WGCNA
magenta module and the pink consensus module shared
26.1% of genes. In keeping with WGCNA results, the
brown, green, and pink consensus modules were also
associated with the severity of airflow limitation
(Additional file 7: Figure S3).
Core of co-expressed genes and related ontologies
We found that, out of the 185 genes shared by the yel-
low WGCNA module and the brown consensus module,
60 genes were nominally associated with FEV1% pre-
dicted at p < 0.1 in lung tissue and sputum (Additional
file 8: Table S4); Gene Ontology analysis showed enrich-
ment in mitochondrial-related ontologies (Fig. 5a,
Additional file 9: Table S5). Three mitochondrial-related
genes were selected for qPCR validation on the basis of
significant association with FEV1% in L1 and L2: NADH
dehydrogenase 1 alpha subcomplex subunit 3
(NDUFA3), Ts Translation Elongation Factor, Mitochon-
drial (TSFM), and MPV17 Mitochondrial Inner Mem-
brane Protein Like 2 (MPV17L2). Additional file 10:
Figure S4 shows the gene expression of these three genes
in L1 and L2 samples, and Fig. 5 shows that the relative
expression of these genes (RQ) was also negatively cor-
related with the severity of airflow limitation in lung tis-
sue obtained from 12 additional COPD patients and 8
controls.
Discussion
We performed a gene co-expression network analysis in
COPD datasets from two separate lung tissue studies,
sputum, and blood. The main results show (1) robust
gene module preservation between the two lung tissue
datasets, with less preservation in sputum and even less
in blood; (2) an association of the modules identified in
the two lung tissue datasets and sputum (but not in
blood) with the severity of airflow limitation (FEV1); and
(3) that these findings were largely reproduced in a
consensus WGCNA network. Taken together, these ob-
servations indicate that major changes in lung tran-
scriptomics in patients with COPD are poorly mirrored
in sputum and are unrelated to those determined in
blood.
Previous studies
Obeidat et al. recently used WGCNA to investigate
blood transcriptomics in COPD patients (n = 238) [23];
however, our study used WGCNA to compare lung tis-
sue, sputum and blood samples in COPD patients.
While we found no gene modules associated with lung
function in blood, Obeidat et al. identified 3 blood mod-
ules associated with FEV1. Differences between the two
studies may be related to their larger sample size (238
vs. 121 patients). The gene ontology enrichments of
these three blood modules [23] were different from
those identified in preserved in lung and sputum in the
present analysis, supporting that lung and blood are in-
dependent compartments in COPD [24], arguing against
Table 2 Module preservation across the different datasets
L2 ECLIPSE-BL ECLIPSE-SP
Module ID # genes Z score Z score Z score
Blue 394 29.91 0.41 1.35
Yellow 329 17.02 10.32 23.76
Brown 345 16.28 1.75 8.86
Salmon 91 11.82 0.00 2.07
Green yellow 99 11.41 2.39 1.37
Light yellow 37 9.38 2.58 2.31
Pink 148 11.57 0.91 −0.71
Light green 51 8.65 4.44 6.16
Tan 95 10.76 −0.47 −0.79
Magenta 142 8.74 2.27 5.44
Red 238 8.03 5.61 1.02
Black 204 7.89 −0.47 0.62
Turquoise 400 6.84 14.23 9.04
Green 241 7.90 1.72 3.21
Midnight blue 76 5.81 0.19 −0.74
Grey60 56 7.26 5.38 5.48
Royal blue 30 6.30 9.02 6.43
Cyan 82 6.04 1.81 0.35
Light cyan 61 4.14 1.07 0.43
Purple 113 2.71 2.58 2.00
Gold 400 2.86 3.53 2.71
Grey 400 2.76 4.09 4.89
Modules are considered preserved if Z score is > 5 (in bold and underlined in
the table), and highly preserved if Z score is > 10 as described in
reference [19]
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the so-called “spill-over” hypothesis, which states that
the systemic manifestations of the disease are the result
of the release to the circulation of lung inflammatory
mediators [25].
Interpretation of findings
Three modules associated with FEV1 were preserved in
lung and sputum. These modules contained genes re-
lated to mitochondrial function, metabolic alterations,
regulation of T cell activation, endocytosis and non-cod-
ing RNA metabolism. Some of these processes have been
previously associated with COPD. For example, meta-
bolic alterations are well documented in airway smooth
muscle (ASM) cells [26], and CTS3 (a driver gene of the
brown module) was previously reported to be causally as-
sociated with COPD [27]. Likewise, the loss of mitochon-
drial biogenesis (production of new mitochondria) and
mitochondrial DNA (mtDNA) appear associated with a
significantly lower body mass index and muscle mass in
COPD [28, 29]. Similarly, inherited mtDNA haplotypes
may also pre-dispose or confer susceptibility to COPD
[30]. Little is known about the effects of mitochondrial
translation or mRNA splicing in COPD, [31] although the
role of mitochondrial and iron abnormalities has been de-
scribed in relationship to a COPD genome-wide associ-
ation gene IREB2 [32]. We validated three of the key
mitochondria-relevant genes encoded by the nuclear gen-
ome by qPCR. TSFM regulates the translation of the
Fig. 2 Association between meta-analysis gene modules and lung function. Heat-map shows the p-values (and effect estimates) of the linear
regression of each module eigengene with FEV1% predicted in each of the four datasets. Yellow denotes lower p-values and blue higher p-
values. The three preserved modules associated with FEV1% predicted are marked with a black outline. For further details on analytical method
see: (https://horvath.genetics.ucla.edu/html/CoexpressionNetwork/Rpackages/WGCNA/Tutorials/)
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Fig. 3 Visual summary of the ontologies in each of the three interesting modules (Treemap in REVIGO (http://revigo.irb.hr/) [22]): (a) Yellow, (b)
Brown, (c) Magenta. Each box is a single ontology cluster, which are joined into superclusters of loosely related terms, shown by the same color
and named with a representative term. Larger boxes have more significant enrichment
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13-mtDNA encoded genes in the mitochondrial matrix,
whereas NDUFA3 encodes an accessory subunit of the
mitochondrial membrane respiratory chain NADH de-
hydrogenase (Complex I). MPV17L2 is a mitochondrial
inner membrane protein that regulates ribosomal assem-
bly and protein synthesis in mitochondria [33].
Functionally, nearly every cell in the lung depends on
mitochondrial metabolic activities, requiring a constant
supply of energy from oxidative phosphorylation. Mito-
chondria are at the hub of cellular metabolism, regulat-
ing the continuous aerobic oxidation of fatty acids and
consuming the end products of glucose, glutamine and
amino acid degradation in order to aerobically produce
ATP from oxygen and H2O [34]. An alteration in any of
the three genes identified in this study may alter bio-
energetic processes, mitochondrial shape, movement
and cellular interactions. From studies of families with
mutations in mitochondrial genes, it is known that im-
paired mitochondrial translation and impaired Complex
I activity results in deficient ATP production and cellular
Table 3 Driver genes in preserved modules associated with
lung function meta-analysis modules in the 4 datasets











Fig. 4 Comparison of the gene composition of the 14 consensus modules (columns) with the 21 meta-analysis modules (rows). Red color indicates
higher concordance. When a meta-analysis module corresponded with more than one consensus module, the module with greater concordance is
outlined with a green square. For further details on analytical method: (https://horvath.genetics.ucla.edu/html/CoexpressionNetwork/JMiller/)
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energy deficit [35]. Accordingly, in COPD mitochondrial
abnormalities have been associated with excessive pro-
duction of mitochondrial Reactive Oxygen Species
(mROS) and abnormalities in ATP production that in
turn lead to enhanced inflammation and cell hyperproli-
feration [36]. Further studies are required to know if the
abnormal mROS observed are related to defects in
translation or whether these defects are consequences of
the continuous exposure to noxious gases and particles,
such as tobacco smoke, in the lung.
Finally, we identified only one module in the
meta-analysis which was preserved and associated with
FEV1% predicted in the two lung tissue datasets (light--
yellow), but not in any other compartment. This module
contained B-cell related genes that have been previously
associated with the presence of emphysema and/or the
severity of airflow limitation [3, 16, 37]. Therefore, our
findings here suggest that the B-cell component of
COPD cannot be readily identified in sputum or blood.
Strengths and limitations
The fact that the two lung studies were performed in
different countries using different array platforms but
still showed good preservation of co-expression and as-
sociation with airflow limitation is a strength of our
study. This reflects both the reproducibility of the tran-
scriptomic changes associated with COPD once the po-
tential confounding effect of active smoking is removed
Fig. 5 Analysis of 60 genes with concordance between the yellow meta-analysis module and brown consensus module and association with
FEV1. (a) Visual summary (Treemap in REVIGO) of the gene ontologies. (b) Correlation (Spearman) between the qPCR expression level (RQ) of
MPV17L2, NDUFA3 and TSFM and FEV1% predicted in 20 additional lung tissue samples
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and that network-based transcriptomic meta-analysis is
a suitable tool to cope with methodological differences
[14, 38]. Among the limitations of our study, we ac-
knowledge that only blood and sputum, but not lung tis-
sue, data were obtained simultaneously from the same
patients. This is the reason why in the current analysis
we used WGCNA, as previous works have described the
ability of the method to assess module preservation across
different tissues and even across different species, over-
coming the limitation of using different subjects [15, 39].
The fact that we do not observe preservation of mod-
ules across sputum and blood that are from the same
individuals also supports the conclusion that there are
co-expressed genes associated with the severity of air-
flow limitation only in lung and sputum.Because our
study was observational, functional evidence based on
animal models or longitudinal human studies are required
to validate the clinical relevance of our observations. We
acknowledge that it would have been desirable to analyse
the mitochondrial gene expression in relation to diverse
COPD clinical parameters (i.e. exacerbations, treatment,
prognosis or blood exam measures) but this data was not
available for the current study and should be addressed in
future investigations.
Finally, in this study it is unclear how much of the dif-
ference in gene expression between samples was due to
differences in cellular composition vs. differences in ex-
pression across cell types.
Conclusions
Using gene expression correlation-based network ana-
lysis, we identified modules of co-expressed genes that
were preserved and associated with the severity of air-
flow limitation in lung tissue and sputum, but not in
blood samples, suggesting that the systemic component
in COPD is independently regulated. The fact that one
of the preserved modules associated with FEV1 was
enriched in mitochondria-related genes supports a role
for mitochondrial dysfunction in the pathobiology of
COPD.
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